Macter International Limited (PSX:MACTER)

Pakistan · Delayed Price · Currency is PKR

242.75

-2.63 (-1.07%)

At close: Oct 19, 2026

Market Cap	11.12B -33.5%
Revenue (ttm)	12.17B +17.5%
Net Income	679.42M -12.5%
EPS	14.83 -12.5%
Shares Out	45.81M
PE Ratio	16.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,248
Open	247.00
Previous Close	245.38
Day's Range	241.41 - 247.00
52-Week Range	235.34 - 381.96
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 22, 2026

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1992

Employees 1,449

Stock Exchange Pakistan Stock Exchange

Ticker Symbol MACTER

Full Company Profile

Financial Performance

In fiscal year 2026, Macter International's revenue was 12.17 billion, an increase of 17.46% compared to the previous year's 10.36 billion. Earnings were 679.42 million, a decrease of -12.49%.

Financial Statements